P2X4 Receptor Protein
Overview
P2X4 receptor (P2X₄R) is a ligand-gated cation channel belonging to the P2X family of ionotropic purinergic receptors. Encoded by the P2RX4 gene, P2X4R is activated by extracellular adenosine triphosphate (ATP) and is a key component of purinergic signaling in the nervous system. The receptor is particularly abundant in microglial cells—the resident immune cells of the central nervous system—but is also expressed in neurons, astrocytes, and other glial populations. P2X4R plays a central role in neuroinflammation and has emerged as a significant target in neurodegeneration research due to its involvement in microglial activation and subsequent neuronal damage.
Function/Biology
P2X4R functions as a trimeric ATP-gated ion channel that permits calcium (Ca²⁺) and sodium (Na⁺) influx upon activation. The receptor contains two transmembrane domains with a large extracellular loop containing the ATP-binding pocket. When ATP binds to the extracellular domain—which can occur in pathological conditions where neurons release ATP—conformational changes open the channel pore, allowing cation entry and membrane depolarization.
...P2X4 Receptor Protein
Overview
P2X4 receptor (P2X₄R) is a ligand-gated cation channel belonging to the P2X family of ionotropic purinergic receptors. Encoded by the P2RX4 gene, P2X4R is activated by extracellular adenosine triphosphate (ATP) and is a key component of purinergic signaling in the nervous system. The receptor is particularly abundant in microglial cells—the resident immune cells of the central nervous system—but is also expressed in neurons, astrocytes, and other glial populations. P2X4R plays a central role in neuroinflammation and has emerged as a significant target in neurodegeneration research due to its involvement in microglial activation and subsequent neuronal damage.
Function/Biology
P2X4R functions as a trimeric ATP-gated ion channel that permits calcium (Ca²⁺) and sodium (Na⁺) influx upon activation. The receptor contains two transmembrane domains with a large extracellular loop containing the ATP-binding pocket. When ATP binds to the extracellular domain—which can occur in pathological conditions where neurons release ATP—conformational changes open the channel pore, allowing cation entry and membrane depolarization.
In microglial cells, P2X4R activation is a critical trigger for the transition from a resting ramified morphology to an activated amoeboid state. This activation promotes the release of pro-inflammatory cytokines including interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). The calcium influx through P2X4R channels activates multiple downstream signaling pathways, including phospholipase C (PLC), phosphatidylinositol 3-kinase (PI3K), and mitogen-activated protein kinase (MAPK) cascades. These pathways collectively orchestrate microglial inflammatory responses.
P2X4R also interacts with other microglial surface molecules, including integrins and CD14, which enhance its signaling capacity. Notably, ivermectin—an allosteric modulator—can potentiate P2X4R function at submaximal ATP concentrations, increasing channel open probability and prolonging current duration.
Role in Neurodegeneration
P2X4R dysfunction contributes to multiple neurodegenerative conditions through dysregulated microglial activation and neuroinflammation. In Alzheimer's disease (AD), excessive P2X4R signaling in microglia promotes amyloid-beta (Aβ) phagocytosis but also intensifies inflammatory responses that damage surrounding neurons. Similarly, in Parkinson's disease (PD), P2X4R activation contributes to α-synuclein-induced microglial neurotoxicity. Amyotrophic lateral sclerosis (ALS) pathology is exacerbated by P2X4R-dependent release of pro-inflammatory mediators that accelerate motor neuron death.
In ischemic stroke and traumatic brain injury, P2X4R activation drives post-injury neuroinflammation that extends damage beyond the initial lesion. The receptor also plays a role in neuropathic pain conditions, where microglial P2X4R activation generates pain hypersensitivity through interactions with neuronal BDNF (brain-derived neurotrophic factor) signaling.
Molecular Mechanisms
P2X4R contributes to neurodegeneration through multiple interconnected mechanisms. ATP released from damaged neurons or activated astrocytes binds P2X4R on microglial surfaces, triggering calcium-dependent activation of NLRP3 inflammasome assembly. This leads to caspase-1 activation and maturation of pro-IL-1β into bioactive IL-1β, a potent neurotoxic cytokine.
Chronic P2X4R signaling promotes a pro-inflammatory microglial phenotype while suppressing neuroprotective responses, including phagocytosis of apoptotic neurons and myelin debris. The sustained elevation of reactive oxygen species (ROS) through NADPH oxidase activation further perpetuates neuronal damage. Additionally, P2X4R-mediated calcium influx regulates the membrane trafficking of additional purinergic receptors, creating signaling amplification loops.
Clinical/Research Significance
P2X4R antagonists represent promising therapeutic candidates for neurodegeneration. The selective antagonist 5-BDBD (5-benzoyl-1,3-diethyl-1,3-diazinane-2,4,6-trione) and the broader P2X antagonist Brilliant Blue G (BBG) have demonstrated neuroprotective effects in preclinical models. BBG crosses the blood-brain barrier and reduces neuroinflammation in multiple disease models, suggesting clinical translation potential.
Modulation of P2X4R activity may provide a therapeutic window balancing anti-inflammatory benefits with preservation of beneficial microglial functions. Ongoing clinical trials are investigating P2X4R targeting in neuropathic pain, with implications for neurodegenerative applications.
Related P2X